| ncRNA name | VEGF shRNA |
| ncRNA Category | shRNA |
| Disease name | age-related macular degeneration (AMD) |
| Species | Homo sapiens |
| Tissues/Cell_line | human RPE cell line ARPE-19 |
| Methods | shRNA knockdown, luciferase reporter assay, RT‐PCR |
| Expression pattern | associated |
| Functional description | The three most potent shRNA‐expressing constructs, sh5, sh7 and sh9, significantly reduced RLuc‐VEGF reporter activity (from 80 to 86%, see Manuscript III) in co‐transfected ARPE‐19 cells in the dual‐luciferase‐based translation assay. |
| PubMed ID | 24953666 |
| Year | 2014 |
| Title | Development of gene therapy for treatment of age-related macular degeneration. |
| Drug-related ncRNA | NA |
Copyright © Institution of Biomedical Big Data, Wenzhou Medical University All rights reserved.